Archived article
Please note that tax, investment, pension and ISA rules can change and the information and any views contained in this article may now be inaccurate.
Faron Pharmaceuticals Ltd - Turku, Finland-based developer of cancer immunotherapies - Non-Executive Chair Tuomo Patsi buys 21,500 ordinary shares at €2.435 per share on Monday for a total of €52,353. Brings Patsi’s shareholding in Faron to 53,265 shares, with 0.05% of company voting rights.
Current stock price: 213.10p, up 5.2% on Wednesday in London
12-month change: More than doubled from 93.50p on July 2, 2024
Copyright 2025 Alliance News Ltd. All Rights Reserved.